Listen to The Lancet Gastroenterology & Hepatology

In conversation with... Peter De Cruz


Episode Artwork
1.0x
0% played 00:00 00:00
Nov 06 2024 14 mins  
Other Episodes

Peter De Cruz (University of Melbourne) discusses the PREDICT-UC trial of intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis.

Download episode Share
Copy URL



Subscribe on Podcast Addict